US FDA grants accelerated approval to infigratinib for metastatic cholangiocarcinoma
Food and Drug Administration granted accelerated approval to infigratinib (Truseltiq, QED Therapeutics, Inc.), a kinase inhibitor ...
Read more
Tag: infigratinib
